NCT03363477View on ClinicalTrials.gov

Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

September 25, 2015

Primary Completion Date

December 1, 2015

Study Completion Date

December 1, 2015

Conditions

Healthy

Interventions

DRUG

Enoxaparin

DRUG

Clexane

Sponsors

Collaborators (1)

PRA Health Sciences

All Listed Sponsors

collaborator

PRA Health Sciences

INDUSTRY

lead

Rovi Pharmaceuticals Laboratories

INDUSTRY